The invention relates to polynucleotide agents targeting the Serpinc1 (AT3) gene, and methods of using such polynucleotide agents to inhibit expression of Serpinc1 and to treat subjects having a bleeding disorder, e.g., a hemophilia.
本发明涉及靶向Serpinc1(AT3)
基因的多核苷酸制剂,以及使用这种多核苷酸制剂抑制Serpinc1的表达和治疗出血性疾病(如血友病)患者的方法。